SC
PYXS icon

Steven Cohen’s Pyxis Oncology PYXS Stock Holding History

Steven Cohen’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
37,092
+5,086
+16% +$9.72K ﹤0.01% 3679
2026
Q1 		$46.7K Sell
32,006
-156,130
-83% -$235K ﹤0.01% 3664
2025
Q4 		$216K Buy
+188,136
New +$664K ﹤0.01% 3610
2023
Q2 		– Sell
-251,800
Closed -$1.01M – 2670
2023
Q1 		$1.01M Buy
+251,800
New +$503K ﹤0.01% 1105

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's PYXS Position: Q2 2026 in Review

Steven Cohen increased its Pyxis Oncology (PYXS) stake by 16% in Q2 2026, buying an estimated $9.72K and bringing the position to 37,092 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3679.

Steven Cohen first reported a position in PYXS in Q1 2023 and has held it in 4 quarters since. The position peaked at $1.01M in Q1 2023. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Steven Cohen held 37,092 shares of Pyxis Oncology worth $112K as of Q2 2026.
  • Steven Cohen bought 5,086 Pyxis Oncology shares in Q2 2026, an estimated $9.72K.
  • Pyxis Oncology made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3679 holding.
  • Steven Cohen first reported a position in Pyxis Oncology in Q1 2023 and has held it in 4 quarters since.
  • Steven Cohen's Pyxis Oncology position peaked at $1.01M in Q1 2023.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.